Last updated on June 2020

A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism


Brief description of study

The goal of the study is to evaluate the efficacy and safety of crizanlizumab in SCD patients with priapism.

Clinical Study Identifier: NCT03938454

Find a site near you

Start Over

NYC H Hospital Queens Cancer Center

New York, NY United States
1.53miles
  Connect »

Jacobi Medical Center

Bronx, NY United States
7.91miles
  Connect »

Montefiore Medical Center

Bronx, NY United States
7.91miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.